DrugPatentWatch Database Preview
Astellas Company Profile
What is the competitive landscape for ASTELLAS, and what generic alternatives to ASTELLAS drugs are available?
ASTELLAS has thirty-three approved drugs.
There are twenty-nine US patents protecting ASTELLAS drugs.
There are three hundred and sixty-six patent family members on ASTELLAS drugs in forty countries and forty-seven supplementary protection certificates in fourteen countries.
Summary for Astellas
International Patents: | 366 |
US Patents: | 29 |
Tradenames: | 18 |
Ingredients: | 14 |
NDAs: | 33 |
Patent Litigation for Astellas: | See patent lawsuits for Astellas |
Drugs and US Patents for Astellas
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | LEXISCAN | regadenoson | SOLUTION;INTRAVENOUS | 022161-001 | Apr 10, 2008 | RX | Yes | Yes | 9,045,519 | ➤ Sign Up | Y | ➤ Sign Up | |||
Astellas | CYCLOCORT | amcinonide | CREAM;TOPICAL | 018116-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
Astellas | LEXISCAN | regadenoson | SOLUTION;INTRAVENOUS | 022161-001 | Apr 10, 2008 | RX | Yes | Yes | 9,085,601 | ➤ Sign Up | Y | ➤ Sign Up | |||
Astellas | XTANDI | enzalutamide | CAPSULE;ORAL | 203415-001 | Aug 31, 2012 | RX | Yes | Yes | 8,183,274 | ➤ Sign Up | ➤ Sign Up | ||||
Astellas | ASTAGRAF XL | tacrolimus | CAPSULE, EXTENDED RELEASE;ORAL | 204096-002 | Jul 19, 2013 | RX | Yes | No | 6,884,433 | ➤ Sign Up | Y | ➤ Sign Up | |||
Astellas | LEXISCAN | regadenoson | SOLUTION;INTRAVENOUS | 022161-001 | Apr 10, 2008 | RX | Yes | Yes | 8,106,029 | ➤ Sign Up | ➤ Sign Up | ||||
Astellas | CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER | ceftizoxime sodium | INJECTABLE;INJECTION | 050589-002 | Oct 3, 1984 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Astellas
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astellas | MYCAMINE | micafungin sodium | INJECTABLE;INTRAVENOUS | 021506-003 | Jun 27, 2006 | 5,376,634 | ➤ Sign Up |
Astellas | CYCLOCORT | amcinonide | CREAM;TOPICAL | 018116-002 | Approved Prior to Jan 1, 1982 | 4,158,055 | ➤ Sign Up |
Astellas | ADENOCARD | adenosine | INJECTABLE;INJECTION | 019937-002 | Oct 30, 1989 | 4,673,563 | ➤ Sign Up |
Astellas | CYCLOCORT | amcinonide | OINTMENT;TOPICAL | 018498-001 | Approved Prior to Jan 1, 1982 | 4,158,055 | ➤ Sign Up |
Astellas | PROGRAF | tacrolimus | INJECTABLE;INJECTION | 050709-001 | Apr 8, 1994 | 5,260,301 | ➤ Sign Up |
Astellas | MYCAMINE | micafungin sodium | INJECTABLE;INTRAVENOUS | 021506-002 | Mar 16, 2005 | 6,265,536 | ➤ Sign Up |
Astellas | ADENOSCAN | adenosine | SOLUTION;INTRAVENOUS | 020059-001 | May 18, 1995 | 5,731,296 | ➤ Sign Up |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for ASTELLAS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Capsules | 0.5 mg, 1 mg, and 5 mg | ➤ Subscribe | 2013-11-15 |
➤ Subscribe | For Injection | 50 mg/vial and 100 mg/vial | ➤ Subscribe | 2014-06-16 |
➤ Subscribe | Injection | 3 mg/mL, 20 mL and 30 mL vials | ➤ Subscribe | 2005-04-16 |
➤ Subscribe | Tablets | 5 mg and 10 mg | ➤ Subscribe | 2009-04-08 |
➤ Subscribe | Capsules | 40 mg | ➤ Subscribe | 2016-08-31 |
➤ Subscribe | Injection | 3 mg/mL, 20 mL and 30 mL vials | ➤ Subscribe | 2005-04-18 |
➤ Subscribe | Injection | 0.08 mg/mL, 5 mL vial | ➤ Subscribe | 2012-04-10 |
International Patents for Astellas Drugs
Country | Document Number | Estimated Expiration |
---|---|---|
Norway | 341322 | ➤ Sign Up |
Norway | 971544 | ➤ Sign Up |
South Africa | 200809098 | ➤ Sign Up |
Norway | 330353 | ➤ Sign Up |
World Intellectual Property Organization (WIPO) | 0132652 | ➤ Sign Up |
South Korea | 100440553 | ➤ Sign Up |
Taiwan | 305842 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Astellas Drugs
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
0791 | Netherlands | ➤ Sign Up | PRODUCT NAME: ISAVUCONAZOL ALS ISAVUCONAZONIUM SULFAAT OF ALS EEN ISAVUCONAZONIUM ZOUT MET ELK ANDER FARMACEUTISCH AANVAARDBAAR ANION, NAAR KEUZE IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, HYDRAAT OF SOLVAAT; REGISTRATION NO/DATE: EU/1/15/1036 20151019 |
133 | Luxembourg | ➤ Sign Up | 91133, EXPIRES: 20181118 |
00477 | Netherlands | ➤ Sign Up | PRODUCT NAME: REGADENOSON ALSMEDE FARMACEUTISCHE AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/10/643/001 20100906 |
2013 00065 | Denmark | ➤ Sign Up | PRODUCT NAME: ENZALUTAMID ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/13/846 20130625 |
2013029 | Lithuania | ➤ Sign Up | PRODUCT NAME: ENZALUTAMIDUM; REGISTRATION NO/DATE: EU/1/13/846 20130621 |
2011 00005 | Denmark | ➤ Sign Up | PRODUCT NAME: REGADENOSON OG SALTE DERAF |
2016000011 | Germany | ➤ Sign Up | PRODUCT NAME: ISAVUCONAZONIUM ALS ISAVUCONAZONIUM-SULFAT ODER ALS SALZ MIT EINEM ANDEREN PHARMAZEUTISCH VERTRAEGLICHEN ANION, SOWIE HYDRATE ODER SOLVATE DAVON; REGISTRATION NO/DATE: EU/1/15/1036 20151015 |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.